Hasil Pencarian - Alain Ravaud
- Menampilkan 1 - 17 hasil dari 17
-
1
Experience with sunitinib in the treatment of metastatic renal cell carcinoma oleh Manuela Schmidinger, James Larkin, Alain Ravaud
Diterbitkan 2012-10-01
Artikel -
2
-
3
-
4
-
5
Effect of prior immunotherapy on the efficacy of chemotherapy in advanced non‐small cell lung cancer: A retrospective study oleh Luc Heraudet, Tara Delon, Rémi Veillon, Charlotte Vergnenègre, Hélène Lepetit, Amaury Daste, Alain Ravaud, Maéva Zysman, Charlotte Domblides
Diterbitkan 2022-05-01
Artikel -
6
Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience oleh Alexis Gonnet, Laura Salabert, Guilhem Roubaud, Vittorio Catena, Véronique Brouste, Xavier Buy, Marine Gross Goupil, Alain Ravaud, Jean Palussière
Diterbitkan 2019-12-01
Artikel -
7
Exploring Biological Predictive Factors of Progression After Surgery in High-Risk Renal Cell Carcinoma: Results From the French Cohort of the Randomized S-TRAC Trial Patients oleh Idir Ouzaid, Idir Ouzaid, Solène Florence Kammerer-Jacquet, Zineddine Khene, Alain Ravaud, Jean-Jacques Patard, Karim Bensalah, Nathalie Rioux-Leclercq
Diterbitkan 2020-06-01
Artikel -
8
265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort oleh Luc Dirix, Frank Beier, Alain Ravaud, Theodore Gourdin, Jean-Laurent Deville, Marco Maruzzo, XiaoZhe Wang, Yulia Vugmeyster, Jeorg Seebeck, Sarah Chennoufi
Diterbitkan 2020-11-01Artikel -
9
A multicenter, phase I, pharmacokinetic study of osimertinib in cancer patients with normal renal function or severe renal impairment oleh Karthick Vishwanathan, Inmaculada Sanchez‐Simon, Bhumsuk Keam, Nicolas Penel, Maria deMiguel‐Luken, Doris Weilert, Andrew Mills, Marcelo Marotti, Martin Johnson, Alain Ravaud
Diterbitkan 2020-08-01
Artikel -
10
Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial oleh Robert J. Motzer, Jean-François Martini, Xinmeng J. Mu, Michael Staehler, Daniel J. George, Olga Valota, Xun Lin, Hardev S. Pandha, Keith A. Ching, Alain Ravaud
Diterbitkan 2022-10-01
Artikel -
11
Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial oleh Ulka Vaishampayan, Patrick Schöffski, Alain Ravaud, Christian Borel, Julio Peguero, Jorge Chaves, John C. Morris, Nuria Kotecki, Martin Smakal, Dongli Zhou, Silke Guenther, Marcis Bajars, James L. Gulley
Diterbitkan 2019-10-01
Artikel -
12
Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France oleh Fanny Porte, Anna Granghaud, Jane Chang, Mairead Kearney, Aya Morel, Ingrid Plessala, Hélène Cawston, Julie Roiz, Ying Xiao, Marie-Noelle Solbes, Prisca Lambert, Alain Ravaud, Yohann Loriot, Antoine Thiery-Vuillemin, Pierre Lévy
Diterbitkan 2024-01-01
Artikel -
13
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma oleh Laurence Albiges, Bernard Escudier, Gwenaelle Gravis, Ronan Flippot, Alain Ravaud, Maxime Meylan, Nathalie Rioux-Leclercq, Marine Gross-Goupil, Gaëlle Fromont, Christophe Passot, Lionnel Geoffrois, Fréderic Rolland, Manon de Vries-Brilland, Jonathan Dauvé, Elena Spirina-Menand, Christine Chevreau, Ellen Blanc, Félix Lefort, Sylvie Negrier
Diterbitkan 2023-11-01
Artikel -
14
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma oleh Renee N Donahue, Jeffrey Schlom, James L Gulley, Mario Sznol, Andreas Schroeder, Julius Strauss, Luc Dirix, Michele Maio, Frank Beier, Alain Ravaud, Jean-Laurent Deville, Marco Maruzzo, XiaoZhe Wang, Yulia Vugmeyster, Sarah Chennoufi, Yo-Ting Tsai, Russell K Pachynski, Theodore S Gourdin, Joerg Seebeck
Diterbitkan 2023-05-01
Artikel -
15
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression oleh Lindsay S. Cooley, Justine Rudewicz, Wilfried Souleyreau, Andrea Emanuelli, Arturo Alvarez-Arenas, Kim Clarke, Francesco Falciani, Maeva Dufies, Diether Lambrechts, Elodie Modave, Domitille Chalopin-Fillot, Raphael Pineau, Damien Ambrosetti, Jean-Christophe Bernhard, Alain Ravaud, Sylvie Négrier, Jean-Marc Ferrero, Gilles Pagès, Sebastien Benzekry, Macha Nikolski, Andreas Bikfalvi
Diterbitkan 2021-10-01
Artikel -
16
Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma oleh Maeva Dufies, Annelies Verbiest, Lindsay S. Cooley, Papa Diogop Ndiaye, Xingkang He, Nicolas Nottet, Wilfried Souleyreau, Anais Hagege, Stephanie Torrino, Julien Parola, Sandy Giuliano, Delphine Borchiellini, Renaud Schiappa, Baharia Mograbi, Jessica Zucman-Rossi, Karim Bensalah, Alain Ravaud, Patrick Auberger, Andréas Bikfalvi, Emmanuel Chamorey, Nathalie Rioux-Leclercq, Nathalie M. Mazure, Benoit Beuselinck, Yihai Cao, Jean Christophe Bernhard, Damien Ambrosetti, Gilles Pagès
Diterbitkan 2021-02-01
Artikel -
17
Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a random... oleh Howard Gurney, Thomas Powles, Asim Amin, Bohuslav Melichar, Camillo Porta, David F McDermott, Toni K Choueiri, Marc-Oliver Grimm, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Hans J Hammers, Saby George, Robert J Motzer, Alain Ravaud, Osvaldo Arén Frontera, Frede Donskov, Philippe Barthélémy, Victoria Neiman, Pamela Salman, Christian K Kollmannsberger, Scott S Tykodi, Raya Leibowitz-Amit, Poul F Geertsen, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir
Diterbitkan 2020-07-01
Artikel